Clinical Trial Supply And Logistics Market (By Service: Logistics & Distribution, Storage & Retention, Packaging, Labeling, and Blinding, Manufacturing, Comparator Sourcing, Other Services (Solutions, Ancillary Supply); By Phase: Phase I, Phase II, Phase III, Phase IV; By End-user: Pharmaceuticals, Biologicals, Medical Device; By Therapeutic Area: Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS and Mental Disorders, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global clinical trial supply and logistics market size is expected to be worth around US$ 12.4 billion by 2030, according to a new report by Vision Research Reports.

The global clinical trial supply and logistics market size was valued at US$ 5.1 billion in 2020 and is anticipated to grow at a CAGR of 9.1% during forecast period 2021 to 2030.

Report Coverage

Growth Factors

The market growth is attributed to the increasing R&D expenditure by pharmaceutical and biopharmaceutical firms and the rising number of clinical trials conducted globally. Furthermore, the market is mostly driven by technological advancements in the supply chain. The growing complexity in clinical studies and increased competition among players are factors responsible for the adoption of new technologies in supply chain management.

clinical trials have increased due to the rising demand for the Covid-19 vaccine. According to the WHO, more than 80 vaccines are currently being studied in clinical trials, with over 180 in the pre-clinical stage. There would be a challenge for logistics related to timelines and access to a large population.

By Service Analysis

The logistics and distribution segment led the market and accounted for a revenue share of over 20.0% in 2020. The segment is also anticipated to register the fastest growth rate throughout the forecast period. This is due to the globalization of clinical trials, an increase in the number of trials involving temperature-sensitive products, and the highly regulated structure of the industry.

Technological developments are positively impacting the global market, both on the inbound and outbound sides. As additional Point of Care (POC) diagnostic tools are developed, there would be a trend toward performing more and more local analyses and transferring less blood, tissue, urine, and other samples to a central site for examination in the future. 

Advances in smart packaging solutions, such as active and passive thermo-regulated products, ensure that shipments stay within suitable temperature ranges while en-route and in storage, protecting the contents of the shipment

By Phase Analysis

The phase III segment held the largest revenue share of over 40.0% in 2020. This is primarily due to a rise in the number of patients enrolled in phase III trials. Investigators in phase III studies compare the novel treatment's safety and efficacy against the current standard of care. 

Phase II clinical trials had the highest number of projects in 2020 and this trend is expected to continue owing to increasing investments in R&D by industry and non-industry sponsors.

By Therapeutic Area Analysis

The cardiovascular diseases segment led the largest revenue share of over 25.0% in 2020. This is due to the large and growing number of cardiovascular research studies and the growing number of companies focused on bringing innovative drugs to the market.

The oncology segment held the second-largest share in 2020. This is due to the high prevalence of cancer. In 2018, cancer was the second biggest cause of death around the world, accounting for 9.6 million fatalities, or one in every six deaths. 

By End-user Analysis

Based on end-user, the pharmaceuticals segment led the market and accounted for over 40.0% share in 2020. This is due to the increased number of clinical studies conducted by pharmaceutical companies and R&D investments by these companies. Besides, the globalization of clinical trials is supporting market growth.

The biologicals segment is projected to expand at the fastest growth rate of 7.3% over the forecast period. This may be largely attributed to the increasing demand for biological products, such as cell and gene therapies, and vaccines and the growing investments in product development

By Regional Analysis

North America held the global market with a share of over 35.0% in 2020. An increase in the number of clinical trials conducted by pharmaceutical companies drives the market in the region. According to ClinicalTrials.gov, the U.S. performs the highest number of clinical trial operations per year.

Asia Pacific is anticipated to register the fastest growth rate of7.8% throughout the forecast period. The region has access to a large and diversified patient pool, cheaper recruitment costs, and favorable policies that make Asia Pacific desirable for clinical studies.

Key Players

• Piramal Pharma Solutions

•  UDG Healthcare

• DHL

• FedEx

•  Movianto

• Packaging Coordinators Inc.

• Thermo Fisher Scientific (Patheon)

• Catalent, Inc.

• Parexel

• Almac Group

• Marken 

Market Segmentation

• Service

  • Logistics & Distribution

  • Storage & Retention

  • Packaging, Labeling, and Blinding

  • Manufacturing

  • Comparator Sourcing

  • Other Services (Solutions, Ancillary Supply)

• Phase

  • Phase I

  • Phase II

  • Phase III

  • Phase IV

• End-user

  • Pharmaceuticals

  • Biologicals

  • Medical Device

• Therapeutic Area

  • Oncology

  • Cardiovascular Diseases

  • Respiratory Diseases

  • CNS and Mental Disorders

  • Others

• Regional

  • North America

    • U.S

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Iran

    • Israel

The Clinical Trial Supply And Logistics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Clinical Trial Supply And Logistics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Clinical Trial Supply And Logistics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trial Supply And Logistics market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Clinical Trial Supply And Logistics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Clinical Trial Supply And Logistics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Clinical Trial Supply And Logistics by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Clinical Trial Supply And Logistics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Clinical Trial Supply And Logistics market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Clinical Trial Supply And Logistics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Clinical Trial Supply And Logistics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Clinical Trial Supply And Logistics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Clinical Trial Supply And Logistics market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Clinical Trial Supply And Logistics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Clinical Trial Supply And Logistics market. These factors have benefited the growth of the global market for Clinical Trial Supply And Logistics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Clinical Trial Supply And Logistics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Clinical Trial Supply And Logistics are as follows:

• History Year: 2017-2020

• Base Year: 2021

• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.